Treeline Biosciences

Precision medicine platform to treat cancer

Treeline Biosciences is a cutting-edge drug discovery company dedicated to creating innovative therapies for cancer, hematology, immunology, and rare diseases.

By combining expertise in mechanistic biology, medicinal chemistry, computational science, and structural biology, Treeline identifies high-potential drug targets and designs breakthrough small-molecule medicines. With a collaborative team and advanced technology, it is transforming the drug discovery process to develop life-changing treatments for patients.

SECTOR

Health Sciences

INVESTED

2021

STATUS

Active

HQ

Watertown, MA

FOUNDERS

Jeffrey Engelman Ph.D
Joshua Bilkenker MD

Subscribe to hear about Arc Ventures' updates and events.